65219-586 : Tyenne 162 mg/.9ml Subcutaneous Injection, Solution


NDC: 65219-586
Labeler: Fresenius Kabi USA, LLC
Product Type: Human Prescription Drug
Drug Name:  Tyenne
Dosage Form: Subcutaneous Injection, Solution
Application #: BLA761275
Rev. Date: 


NDC Package Codes:

  • 65219-586-04: 1 SYRINGE, GLASS IN 1 CARTON (65219‑586‑04) / .9 ML IN 1 SYRINGE, GLASS

Active Ingredients:

  • Tocilizumab

Dosage Strength:

  • 162 mg/.9mL

Pharmaceutical Classes:

  • Interleukin 6 Receptor Antagonists [MoA]
  • Interleukin-6 Receptor Antagonist [EPC]

Related Products:

Based on records with the same trade name.
  • 65219-584 Tyenne 162 mg/.9ml Subcutaneous Injection, Solution by Fresenius Kabi USA, LLC
  • 65219-590 Tyenne 80 mg/4ml Intravenous Injection, Solution, Concentrate by Fresenius Kabi USA, LLC
  • 65219-592 Tyenne 200 mg/10ml Intravenous Injection, Solution, Concentrate by Fresenius Kabi USA, LLC
  • 65219-594 Tyenne 400 mg/20ml Intravenous Injection, Solution, Concentrate by Fresenius Kabi USA, LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 65219-586 QR Code

< Prev: 65219-584Next: 65219-590 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.